Retrospective clinical studies show that the incidence of AF is decreased in patients treated with angiotensin-receptor blockers (ARBs) or ACE inhibitors (Vermes, 2003; L’Allier, 2004). The gene discussed is ACE; the disease is atrial fibrillation.